Data coverage, completeness and provenance for PACIFIC EDGE LIMITED in the Stock Market API — Health Care · Diagnostics & Research.
Source date: 2026-10-30T00:46:31. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.1900 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.1900 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.1900 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.1900 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.1900 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/PEB/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the stratification and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up in microhematuria patients; Cxbladder Detect, which improve practice workflow and efficiency in urological care; Cxbladder Triage Plus, a non-invasive surveillance alternative that can reduce the burden of repeated cystoscopy in patients; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a recurrent non-muscle invasive bladder cancer. In addition, the company is developing products for bladder, gastric, colorectal and endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Website: https://www.pacificedgedx.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/PEB/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-03-31 | 30 | yfinance | ||||
| FY2025 (AUD) | 2025-03-31 | 30 | yfinance | ||||
| FY2024 (AUD) | 2024-03-31 | 30 | yfinance | ||||
| FY2023 (AUD) | 2023-03-31 | 30 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/PEB
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/PEB/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/PEB/metrics/summary
Dated press releases and announcements with source links.
GET /api/v1/companies/PEB/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/PEB
Free tier — instant API key. Built for AI agents.